Heartflow (NASDAQ:HTFL – Get Free Report) was upgraded by research analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research note issued to investors on Sunday, Wall Street Zen reports.
HTFL has been the topic of several other research reports. Wells Fargo & Company raised their target price on shares of Heartflow from $39.00 to $70.00 and gave the stock an “overweight” rating in a report on Friday. JPMorgan Chase & Co. lifted their target price on shares of Heartflow from $35.00 to $45.00 and gave the stock an “overweight” rating in a research note on Friday, August 14th. Stifel Nicolaus upped their price target on shares of Heartflow from $45.00 to $70.00 and gave the company a “buy” rating in a report on Friday. Canaccord Genuity Group increased their price target on shares of Heartflow from $56.00 to $69.00 and gave the company a “buy” rating in a research report on Friday. Finally, UBS Group assumed coverage on shares of Heartflow in a report on Wednesday, September 9th. They issued a “neutral” rating and a $55.00 price target on the stock. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $60.12.
Get Our Latest Research Report on Heartflow
Heartflow Stock Performance
Heartflow (NASDAQ:HTFL – Get Free Report) last announced its quarterly earnings results on Thursday, November 12th. The company reported ($0.03) EPS for the quarter, topping analysts’ consensus estimates of ($0.18) by $0.15. Heartflow had a negative return on equity of 20.42% and a negative net margin of 33.11%. The business had revenue of $72.86 million for the quarter. During the same period last year, the firm earned ($0.27) earnings per share. Sell-side analysts expect that Heartflow will post -0.75 EPS for the current year.
Insiders Place Their Bets
In other news, CEO John Farquhar sold 38,900 shares of Heartflow stock in a transaction that occurred on Tuesday, November 10th. The stock was sold at an average price of $55.74, for a total value of $2,168,286.00. Following the sale, the chief executive officer directly owned 251,983 shares in the company, valued at approximately $14,045,532.42. This trade represents a 13.37% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Vikram Verghese sold 3,587 shares of Heartflow stock in a transaction that occurred on Monday, November 9th. The stock was sold at an average price of $53.15, for a total value of $190,649.05. Following the completion of the sale, the chief financial officer owned 149,587 shares in the company, valued at approximately $7,950,549.05. This represents a 2.34% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last 90 days, insiders sold 332,403 shares of company stock worth $16,602,786. 7.70% of the stock is currently owned by company insiders.
Institutional Trading of Heartflow
Several large investors have recently added to or reduced their stakes in the stock. XXEC Inc. bought a new stake in Heartflow during the 2nd quarter valued at approximately $2,524,764,000. Quantinno Capital Management LP purchased a new position in shares of Heartflow during the 1st quarter worth approximately $1,734,000. Sei Investments Co. raised its position in shares of Heartflow by 342.5% in the 1st quarter. Sei Investments Co. now owns 67,048 shares of the company’s stock worth $1,631,000 after acquiring an additional 51,895 shares in the last quarter. Bank of New York Mellon Corp bought a new position in shares of Heartflow in the 2nd quarter worth approximately $19,096,000. Finally, Handelsbanken Fonder AB purchased a new position in shares of Heartflow in the 2nd quarter valued at approximately $910,000.
Key Heartflow News
Investors following HTFL have been watching these news items:
- Positive Sentiment: Q3 revenue rose 57% year over year to $72.9 million, above the roughly $65.2 million consensus. The quarterly loss was $0.03 per share, narrower than analysts’ expected $0.18 loss and the $0.27 loss a year earlier. Q3 results
- Positive Sentiment: Wells Fargo, Canaccord Genuity, Stifel and Baird raised their price targets to $68–$70 and maintained positive ratings, reflecting improved analyst expectations. Wells Fargo rating Canaccord Genuity rating Stifel rating Baird rating
- Negative Sentiment: A report said Heartflow’s CEO sold about $2.17 million worth of stock. Insider selling can concern investors, though the report alone does not establish the reason for the sale. CEO stock sale
About Heartflow
HeartFlow, Inc. is a medical technology company that develops noninvasive tools to help clinicians assess coronary artery disease. Its platform analyzes coronary CT angiography scans to create personalized models of a patient’s coronary arteries and provide information that can support diagnosis and treatment planning. The company’s offerings include HeartFlow FFR CT Analysis, which estimates blood flow and the effects of artery narrowing, and tools for assessing coronary plaque. The technology combines medical imaging with computational analysis and artificial intelligence, giving clinicians information without requiring an invasive procedure to measure blood flow.
See Also
- Five stocks we like better than Heartflow
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
- Is It Too Late to Buy the Dip? 3 Corners of the Market Still Offering Real Value
- Why Equinix and Digital Realty Benefit From Data Center Zoning Battles
- 3 GARP Plays That Could Offer a Better Balance as Markets Turn Volatile
Receive News & Ratings for Heartflow Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heartflow and related companies with MarketBeat.com's FREE daily email newsletter.
